Article
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.
BMJ (Clinical research ed.) - 20 Jul 2012
Hollands Gareth J, Whitwell Sophia C L, Parker Richard A, Prescott Natalie J, Forbes Alastair, Sanderson Jeremy, Mathew Christopher G, Lewis Cathryn M, Watts Sally, Sutton Stephen, Armstrong David, Kinmonth Ann Louise, Prevost A Toby, Marteau Theresa M
Abstract excerpt
OBJECTIVE: To test the hypothesis that communicating risk of developing Crohn's disease based on genotype and that stopping smoking can reduce this risk, motivates behaviour change among smokers at familial risk. DESIGN: Parallel group, cluster randomised controlled trial. SETTING: Families with Crohn's disease in the United Kingdom. PARTICIPANTS: 497 smokers (mean age 42.6 (SD 14.4) years) who were first degree...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
